| 1 |
Reynolds CH. Clinical efficacy of rhIL-11[J]. Oncology (Williston Park), 2000, 14(9 Suppl 8):32-40.
|
| 2 |
Sun XF, Guan ZZ, Huang H, et al. Clinical study of rhIL-11 for prevention and treatment of chemotherapy-inducedthrombocytopenia[J]. Ai Zheng, 2002, 21(8):892-895.
|
| 3 |
Xiao Y, Liu J, Huang XE, et al. A Clinical Study on Juheli (Recombinant Human Interleukin-11) in the Second Prevention of Chemotherapy Induced Thrombocytopenia[J]. Asian Pac J Cancer Prev, 2016, 17(2):485-489.
|
| 4 |
中国抗癌协会临床肿瘤学协作专家委员会. 肿瘤化疗所致血小板减少症诊疗中国专家共识(2014版)[J]. 中华肿瘤杂志，2014, 36(11):876-879.
|
| 5 |
Kuter DJ. Managing thrombocytopenia associated with cancer chemotherapy [J]. Oncology (Williston Park), 2015, 29(4):282-294.
|
| 6 |
Goldman SC, Bracho F, Davenport V, et al. Feasibility study of IL-11 and granulocyte colony-stimulating factor after myelosuppressive chemotherapy to mobilize peripheral blood stem cells from heavily pretreated patients[J]. J Pediatr Hematol Oncol, 2001, 23(5):300-305.
|
| 7 |
Lei W, Liang J, Chen WG, et al. Effectiveness and safety of recombinant human interleukin-11 in the treatment of chemotherapy-induced thrombocytopenia[J]. Zhonghua Zhong Liu Za Zhi, 2006, 28(7):542-544.
|
| 8 |
Wang XY, Feng FY, Song ST. Phase Ⅱ clinical trial on China manufactured recombinant human interleukin-11 derivative in the prevention and treatment of chemotherapy-induced thrombocytopenia[J]. Zhonghua Zhong Liu Za Zhi, 2005, 27(6):373-376.
|
| 9 |
Smith JW 2nd, Tolerability and side-effect profile of rhIL-11[J]. Oncology (Williston Park), 2000, 14(9 Suppl 8):41-47.
|
| 10 |
Druey KM, Greipp PR. Narrative review: the systemic capillary leak syndrome[J]. Ann Intern Med, 2010, 153(2):90-98.
|
| 11 |
Mertz P, Lebrun-Vignes B, Salem JE, et al. Characterizing drug-induced capillary leak syndromes using the Wold Health Organization VigiBase[J]. J Allergy Clin Immunol, 2019, 143(1):433-436.
|
| 12 |
Siddall E, Khatri M, Radhakrishnan J. Capillary leak syndrome: etiologies, pathophysiology, and management[J]. Kidney Int, 2017, 92(1):37-46.
|
| 13 |
洪昆峣，林新祝. 毛细血管渗漏综合征诊治进展[J]. 中国新生儿科杂志，2016, 4:313-315.
|
| 14 |
Kai-Feng W, Hong-Ming P, Hai-Zhou L, et al. Interleukin-11-induced capillary leak syndrome in primary hepatic carcinoma patients with thrombocytopenia[J]. BMC Cancer, 2011, 11:204.
|
| 15 |
Liu Z, Li de C, Zhu YP. Interleukin-11-induced capillary leak syndrome companied with abdominal chylous leakage in primary sigmoid carcinoma patients with thrombocytopenia[J]. J Cancer Res Ther, 2015, 11(4):1024.
|
| 16 |
Wilde MI, Faulds D. Oprelvekin: a review of its pharmacology and therapeutic potential in chemotherapy-induced thrombocytopenia[J]. BioDrugs, 1998, 10(2):159-171.
|
| 17 |
Bajwa R, Starr J, Daily K. Gemcitabine-induced chronic systemic capillary leak syndrome[J]. BMJ Case Rep, 2017, 2017: doi: 10.1136/bcr-2017-221068. |
| 18 |
Zhang F, Yang J, Li Z. Trastuzumab-induced systemic capillary leak syndrome in a breast cancer patient[J]. Pathol Oncol Res, 2014, 20(2):435-437.
|
| 19 |
He S, Lingyun Z, Yunpeng L. Analysis of postoperative chemotherapy-related anemia in elderly cancer patients[J]. Zhonghua Zhong Liu Za Zhi, 2015, 37(4):290-292.
|
| 20 |
Muñoz-Langa J, De Castro J, Gascó P, et al. Chemotherapy-associated anemia in patients with lung cancer: an epidemiological, retrospective and multicenter study[J]. Future Oncol, 2015, 11(11):1665-1674.
|
| 21 |
Dykstra KH, Rogge H, Stone A, et al. mechanism and amelioration of recombinant human interleukin-11 (rhIL-11) induced anemia in healthy subjects[J]. J Clin Pharmacol, 2000, 40(8):880-888.
|
| 22 |
Fathollahipour S, Patil PS, Leipzig ND. Oxygen Regulation in Development：Lessons from Embryogenesis towards Tissue Engineering[J]. Cells Tissues Organs, 2018:1-22.
|
| 23 |
Bliss S, Anemia and Oxygen Delivery[J]. Vet Clin North Am Small Anim Pract, 2015, 45(5):917-930.
|
| 24 |
Nitz R, Lokau J, Aparicio-Siegmund S, et al. Modular organization of Interleukin-6 and Interleukin-11 α-receptors[J]. Biochimie, 2015, 119:175-182.
|
| 25 |
Wu G, Cheng M, Huang H, et al. A variant of IL6R is associated with the recurrence of atrial fibrillation after catheter ablation in a Chinese Han population[J]. PLoS One, 2014, 9(6):e99623.
|
| 26 |
Xu J, Ren JF, Mugelli A, et al. Age-dependent atrial remodeling induced by recombinant human interleukin-11: implications for atrial flutter/fibrillation[J]. J Cardiovasc Pharmacol, 2002, 39(3):435-440.
|
| 27 |
Ando SI. Influence of hypoxia induced by sleep disordered breathing in case of hypertension and atrial fibrillation[J]. J Cardiol, 2018, 72(1):10-18.
|
| 28 |
Medhora M, Gao F, Glisch C, et al. Whole-thorax irradiation induces hypoxic respiratory failure, pleural effusions and cardiac remodeling[J]. J Radiat Res, 2015, 56(2):248-260.
|
| 29 |
Siddall E, Khatri M, Radhakrishnan J. Capillary leak syndrome: etiologies, pathophysiology, and management[J]. Kidney Int, 2017, 92(1):37-46.
|
| 30 |
Druey KM, Parikh SM. Idiopathic systemic capillary leak syndrome (Clarkson disease)[J]. J Allergy Clin Immunol, 2017, 140(3):663-670.
|
| 31 |
Brambatti M, Connolly SJ, Gold MR, et al. Temporal relationship between subclinical atrial fibrillation and embolic events[J]. Circulation, 2014, 129(21):2094-2099.
|